[Paclitaxel should be included in standard therapy of ovarian carcinoma].
Tropé
Claes
C
Radiumhospitalet, Oslo. c.g.trope@klinmed.uni.no
Kaern
Janne
J
Saeter
Gunnar
G
Gore
Martin
M
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel